Clinical Trial Update: Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation. [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing immune responses of GSK's HPV vaccine after manufacturing process adaptation; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillomavirus Infection
• Papillomavirus Vaccines

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus, Papillomavirus Vaccines | Phase 3 | Status: COMPLETED | Results posted: 2017-03-17